These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11765310)

  • 1. Do hypolipidemic drugs lower medical expenses?
    Kauffman JM
    Pharmacotherapy; 2001 Dec; 21(12):1583-4; discussion 1584-6. PubMed ID: 11765310
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in liver and spleen scans of patients during treatment with two hypolipidemic drugs.
    Dujovne CA; Strauss HW
    Radiology; 1971 Mar; 98(3):682-4. PubMed ID: 4925561
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
    Willich SN; Müller-Nordhorn J; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H
    Am Heart J; 2004 Dec; 148(6):1060-7. PubMed ID: 15632894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidemic agents--newly approved.
    Duncan GG
    Metabolism; 1967 Sep; 16(9):775-6. PubMed ID: 4860365
    [No Abstract]   [Full Text] [Related]  

  • 5. [The control of cholesterol by drugs].
    Stoy DB
    Servir; 1990; 38(6):291-6. PubMed ID: 2291110
    [No Abstract]   [Full Text] [Related]  

  • 6. Helping patients take cholesterol-lowering drugs.
    Stoy DB
    Am J Nurs; 1989 Dec; 89(12):1631-3. PubMed ID: 2589421
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 8. The phenomenon of regression to the mean and clinical investigation of blood cholesterol lowering drugs.
    Boissel JP; Duperat B; Leizorovicz A
    Eur J Clin Pharmacol; 1980; 17(3):227-30. PubMed ID: 6988223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problem of compliance to cholesterol altering therapy.
    Insull W
    J Intern Med; 1997 Apr; 241(4):317-25. PubMed ID: 9159603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers.
    Am J Health Syst Pharm; 1997 Mar; 54(6):626. PubMed ID: 9075489
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating economic analysis into clinical trials.
    Imai K; Zhang P
    Lancet; 2005 May 21-27; 365(9473):1749-50. PubMed ID: 15910936
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins for stroke: the second story?
    Plutzky J; Ridker PM
    Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of halofenate on serum uric acid.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP
    Clin Pharmacol Ther; 1973; 14(3):371-3. PubMed ID: 4572799
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular primary prevention: how high should we set the bar?
    Prasad V; Vandross A
    Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb.
    Bertolini S; Elicio N; Daga A; Degl'Innocenti ML; Balestreri R; Fusi MG; Cotta Ramusino AM; Carozzi A
    Eur J Clin Pharmacol; 1988; 34(1):25-8. PubMed ID: 3282894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do patients really use their cholesterol medicines?
    Harv Heart Lett; 1998 Sep; 9(1):1. PubMed ID: 9734242
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost of prevention. The case of lipid lowering.
    Yusuf S; Anand S
    Circulation; 1996 May; 93(10):1774-6. PubMed ID: 8635252
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol lowering drugs.
    Amarasingham R
    N Z Med J; 1990 Mar; 103(886):138. PubMed ID: 2181355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expensive pharmacological prevention of atherosclerosis].
    Partanen J
    Duodecim; 2001; 117(15):1519-20. PubMed ID: 12181960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.